The Financial Services Authority (FSA) review on structured products will continue well into next year due to the complexity of the issue; further actions against advisers and investment firms are not out of the question, an FSA spokeswoman told SRP. "The structured products review is an ongoing process and we are still looking at the advice process on such products and also how the products were packaged and marketed in the UK," she said. This remark follows today's announcement from the FSA
